Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidates
Condition(s):Ductal Carcinoma in SituLast Updated:July 27, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Ductal Carcinoma in SituLast Updated:July 27, 2023Completed
Condition(s):Ductal Carcinoma In SituLast Updated:October 2, 2008Unknown status
Condition(s):Ductal Carcinoma in SituLast Updated:March 27, 2024Recruiting
Condition(s):Collecting Duct Carcinoma (Kidney)Last Updated:March 9, 2021Completed
Condition(s):Ductal Carcinoma In SituLast Updated:September 23, 2020Completed
Condition(s):Ductal Carcinoma in SituLast Updated:July 8, 2015Terminated
Condition(s):Breast Ductal Carcinoma in SituLast Updated:August 6, 2019Recruiting
Condition(s):Ductal Carcinoma in SituLast Updated:April 9, 2020Terminated
Condition(s):Carcinoma, Ductal, BreastLast Updated:September 17, 2019Terminated
Condition(s):Non-curative Resectable Bile Duct CarcinomaLast Updated:November 18, 2009Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.